Cancer
Data on cancer described by A.L. Mayburd et al
Published in Medical Letter on the CDC and FDA, May 4th, 2008
According to recent research from the United States, "New efforts to guide and prioritize the selection of cancer drug targets are urgently needed, as is evident by the slow development of novel anti-cancer agents and the narrow therapeutic index of existing drugs. Given these limitations, the current study was conducted to explore the classification features defining the therapeutic success that can result from targeting a particular gene."
"Classification was based on extracting features specific to known successful anti-cancer targets and combining them in a linear classifier, resulting in calculation of an enrichment score for each gene. Extended description, the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Clinical Trial Research
Risk of death from rofecoxib in some trials may have been misrepresented by study sponsor - RF Surgical Systems, Inc.
Virginia Commonwealth University Medical Center Adopts Cutting-Edge Technology to Enhance Patient Safety in the - Dementia Therapy
Studies from Yale University, Department of Psychiatry update current data on dementia therapy - HIV/AIDS Therapy
Studies from University of Southern California reveal new findings on HIV/AIDS therapy - Life Sciences
Research from Food & Drug Administration provides new data on life sciences - Life Sciences
Research from Tanabe Seiyaku Co., Ltd., Research Department provides new data about life sciences - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
